Jane Street’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$688K Sell
222,796
-57,964
-21% -$179K ﹤0.01% 3332
2025
Q1
$980K Buy
+280,760
New +$980K ﹤0.01% 3080
2024
Q4
Sell
-66,910
Closed -$258K 5753
2024
Q3
$258K Sell
66,910
-136,488
-67% -$525K ﹤0.01% 5005
2024
Q2
$629K Buy
203,398
+159,279
+361% +$492K ﹤0.01% 4282
2024
Q1
$114K Sell
44,119
-52,390
-54% -$135K ﹤0.01% 5226
2023
Q4
$241K Buy
+96,509
New +$241K ﹤0.01% 4848
2023
Q2
Sell
-136,288
Closed -$413K 5275
2023
Q1
$413K Buy
136,288
+29,742
+28% +$90.1K ﹤0.01% 3878
2022
Q4
$248K Buy
106,546
+87,677
+465% +$204K ﹤0.01% 4174
2022
Q3
$36K Sell
18,869
-23,732
-56% -$45.3K ﹤0.01% 5180
2022
Q2
$115K Sell
42,601
-39,213
-48% -$106K ﹤0.01% 4683
2022
Q1
$244K Sell
81,814
-271,066
-77% -$808K ﹤0.01% 4512
2021
Q4
$1.37M Buy
352,880
+130,119
+58% +$506K ﹤0.01% 2364
2021
Q3
$956K Buy
222,761
+201,526
+949% +$865K ﹤0.01% 2693
2021
Q2
$65K Sell
21,235
-32,127
-60% -$98.3K ﹤0.01% 4880
2021
Q1
$177K Buy
53,362
+14,298
+37% +$47.4K ﹤0.01% 4341
2020
Q4
$139K Buy
39,064
+22,239
+132% +$79.1K ﹤0.01% 3563
2020
Q3
$53K Sell
16,825
-89,356
-84% -$281K ﹤0.01% 3560
2020
Q2
$194K Buy
106,181
+33,256
+46% +$60.8K ﹤0.01% 3430
2020
Q1
$73K Buy
+72,925
New +$73K ﹤0.01% 3181
2019
Q3
Sell
-167,188
Closed -$348K 3358
2019
Q2
$348K Buy
+167,188
New +$348K ﹤0.01% 2604
2017
Q4
Sell
-10,983
Closed -$68K 3006
2017
Q3
$68K Buy
+10,983
New +$68K ﹤0.01% 2769
2015
Q4
Sell
-25,374
Closed -$155K 2566
2015
Q3
$155K Buy
+25,374
New +$155K ﹤0.01% 2249
2015
Q2
Sell
-10,200
Closed -$178K 2473
2015
Q1
$178K Buy
+10,200
New +$178K ﹤0.01% 2010
2014
Q4
Sell
-54,179
Closed -$1.15M 1758
2014
Q3
$1.15M Buy
+54,179
New +$1.15M 0.01% 625
2014
Q2
Sell
-21,400
Closed -$460K 2210
2014
Q1
$460K Buy
+21,400
New +$460K 0.01% 1407